Aberrant wound healing and TGF-beta production in the autoimmune-prone MRL/+ mouse

被引:62
作者
Kench, JA [1 ]
Russell, DM
Fadok, VA
Young, SK
Worthen, GS
Jones-Carson, J
Henson, JE
Henson, PM
Nemazee, D
机构
[1] Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80206 USA
[3] Scripps Res Inst, La Jolla, CA 92037 USA
关键词
lupus; skin; inflammation; macrophages; in vivo animal models;
D O I
10.1006/clim.1999.4754
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Wound healing is a complex process that, involves inflammation, apoptosis, growth, and tissue remodeling. The autoimmune-prone inbred mouse strain MRL/+ manifests accelerated and extensive healing to ear punch wounds, suggesting a Pink between immune defects and wound healing. Prior studies with lupus-prone mice have shown that hematopoietic cells of lupus-prone strains can transfer disease to otherwise non-autoimmune-prone recipients. In this study we performed reciprocal bone marrow transfers between MRL and the control strain B10.BR and found that radioresistant MRL/+ host cells, rather than hematopoietic cells, are required for the healing response. Ww have also made the novel observations that, compared to normal controls, MRL/+ hematopoietic cells overproduce TGF-beta 1 and manifest impaired inflammatory responses to lipopolysaccharide challenge. These features suggest that the aberrant wound healing phenotype of MRL mice is independent of their propensity to develop autoimmunity. (C) 1999 Academic Press.
引用
收藏
页码:300 / 310
页数:11
相关论文
共 69 条
  • [1] Alleva DG, 1997, J IMMUNOL, V159, P5610
  • [2] Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta 1 levels
    Ashcroft, GS
    Dodsworth, J
    vanBoxtel, E
    Tarnuzzer, RW
    Horan, MA
    Schultz, GS
    Ferguson, MWJ
    [J]. NATURE MEDICINE, 1997, 3 (11) : 1209 - 1215
  • [3] ASHCROFT GS, 1995, J ANAT, V187, P1
  • [4] Ashcroft GS, 1998, LAB INVEST, V78, P47
  • [5] ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
  • [6] EXPRESSION AND SECRETION OF TYPE-BETA TRANSFORMING GROWTH-FACTOR BY ACTIVATED HUMAN MACROPHAGES
    ASSOIAN, RK
    FLEURDELYS, BE
    STEVENSON, HC
    MILLER, PJ
    MADTES, DK
    RAINES, EW
    ROSS, R
    SPORN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) : 6020 - 6024
  • [7] TGF-BETA RECEPTORS AND ACTIONS
    ATTISANO, L
    WRANA, JL
    LOPEZCASILLAS, F
    MASSAGUE, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1222 (01): : 71 - 80
  • [8] Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines
    Bridoux, F
    Badou, A
    Saoudi, A
    Bernard, I
    Druet, E
    Pasquier, R
    Druet, P
    Pelletier, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (10) : 1769 - 1775
  • [9] Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides
    Choi, BM
    Kwak, HJ
    Jun, CD
    Park, SD
    Kim, KY
    Kim, HR
    Chung, HT
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 1996, 74 (02) : 144 - 150
  • [10] A new murine model for mammalian wound repair and regeneration
    Clark, LD
    Clark, RK
    Heber-Katz, E
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 88 (01): : 35 - 45